Live Breaking News & Updates on Agile therapeutics daily

Stay informed with the latest breaking news from Agile therapeutics daily on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Agile therapeutics daily and stay connected to the pulse of your community

Head to Head Contrast: Agile Therapeutics (NASDAQ:AGRX) and Indivior (NASDAQ:INDV)

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) and Indivior (NASDAQ:INDV – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 10.9% of Agile Therapeutics shares […]

New-jersey , United-states , United-kingdom , Virginia , Aelis-farma , Alar-pharmaceuticals-inc , Agile-therapeutics-inc , Agile-therapeutics , Get-free-report , Given-agile-therapeutic , North-chesterfield , Agile-therapeutics-daily

Indivior (NASDAQ:INDV) versus Agile Therapeutics (NASDAQ:AGRX) Head to Head Comparison

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) and Indivior (NASDAQ:INDV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Profitability This table compares Agile Therapeutics and Indivior’s net […]

United-states , Virginia , United-kingdom , New-jersey , Aelis-farma , Alar-pharmaceuticals-inc , Agile-therapeutics-inc , Agile-therapeutics , Get-free-report , Given-agile-therapeutic , North-chesterfield , Agile-therapeutics-daily

Agile Therapeutics (NASDAQ:AGRX) Receives New Coverage from Analysts at StockNews.com

Agile Therapeutics (NASDAQ:AGRX) Receives New Coverage from Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Vanguard-group-inc , Armistice-capital , Blackrock-inc , Agile-therapeutics-inc , Virtu-financial , Maxim-group , Agile-therapeutics-company-profile , Agile-therapeutics , Free-report , Street-corp

Short Interest in Agile Therapeutics, Inc. (NASDAQ:AGRX) Rises By 62.7%

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 361,300 shares, an increase of 62.7% from the February 29th total of 222,100 shares. Based on an average daily volume of 698,200 shares, […]

United-states , Nasdaq , Armistice-capital , Agile-therapeutics-inc , Vanguard-group-inc , Maxim-group , Blackrock-inc , Agile-therapeutics , Get-free-report , Therapeutics-stock-down , Street-corp

Agile Therapeutics (NASDAQ:AGRX) Lowered to "Sell" at StockNews.com

Agile Therapeutics (NASDAQ:AGRX) Lowered to "Sell" at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Agile-therapeutics-inc , Agile-therapeutics-company-profile , Nasdaq , Blackrock-inc , Maxim-group , Virtu-financial , Vanguard-group-inc , Agile-therapeutics , Free-report , Therapeutics-stock-down

Agile Therapeutics (NASDAQ:AGRX) Shares Pass Above 50 Day Moving Average of $2.03

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Free Report) shares crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $2.03 and traded as high as $2.03. Agile Therapeutics shares last traded at $1.88, with a volume of 74,942 shares traded. Wall Street Analyst Weigh […]

United-states , Maxim-group , Virtu-financial , Blackrock-inc , Renaissance-technologies , Nasdaq , Agile-therapeutics-inc , Agile-therapeutics , Get-free-report , Street-corp , Street-group

Agile Therapeutics (NASDAQ:AGRX) Now Covered by Analysts at StockNews.com

Agile Therapeutics (NASDAQ:AGRX) Now Covered by Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Blackrock-inc , Maxim-group , Virtu-financial , Renaissance-technologies , Agile-therapeutics-inc , Agile-therapeutics , Get-free-report , Therapeutics-stock-down , Street-group , State-street-corp

Agile Therapeutics (NASDAQ:AGRX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised Agile Therapeutics from a hold rating to a buy rating and set a $5.00 target price on the […]

United-states , Virtu-financial , Agile-therapeutics-inc , Blackrock-inc , Renaissance-technologies , Maxim-group , Agile-therapeutics , Free-report , Get-free-report , Street-group , State-street-corp

Agile Therapeutics (NASDAQ:AGRX) versus Merck KGaA (OTCMKTS:MKGAF) Head to Head Survey

Agile Therapeutics (NASDAQ:AGRX) versus Merck KGaA (OTCMKTS:MKGAF) Head to Head Survey
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , New-jersey , Germany , Merck-kga , Pfizer-inc , Agile-therapeutics-inc , Merck-kgaa , Debiopharm-international , Agile-therapeutics , Get-free-report , Given-agile-therapeutic

Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report released on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group upgraded Agile Therapeutics from a hold rating to a buy rating and set a $5.00 price target for the company […]

United-states , Virtu-financial , Agile-therapeutics-inc , Blackrock-inc , Agile-therapeutics-company-profile , Maxim-group , Renaissance-technologies , Agile-therapeutics , Free-report , Get-free-report , Street-corp